Payments to Acquire Property, Plant, and Equipment of CytomX Therapeutics, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
CytomX Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • CytomX Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $119,000, a 3.5% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $220,000, a 29% decline from 2024.
  • CytomX Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $310,000, a 63% decline from 2023.
  • CytomX Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $840,000, a 52% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

CytomX Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $220,000 -$90,000 -29% 01 Jan 2025 31 Dec 2025 10-K 16 Mar 2026 2025 FY
2024 $310,000 -$530,000 -63% 01 Jan 2024 31 Dec 2024 10-K 16 Mar 2026 2025 FY
2023 $840,000 -$900,000 -52% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $1,740,000 +$131,000 +8.1% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024 2023 FY
2021 $1,609,000 -$700,000 -30% 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
2020 $2,309,000 -$1,188,000 -34% 01 Jan 2020 31 Dec 2020 10-K/A 27 Mar 2023 2021 FY
2019 $3,497,000 -$291,000 -7.7% 01 Jan 2019 31 Dec 2019 10-K/A 27 Mar 2023 2021 FY
2018 $3,788,000 +$2,229,000 +143% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $1,559,000 -$617,000 -28% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $2,176,000 +$582,000 +37% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019 2018 FY
2015 $1,594,000 -$69,000 -4.1% 01 Jan 2015 31 Dec 2015 10-K 07 Mar 2018 2017 FY
2014 $1,663,000 +$931,000 +127% 01 Jan 2014 31 Dec 2014 10-K 02 Mar 2017 2016 FY
2013 $732,000 01 Jan 2013 31 Dec 2013 10-K 07 Mar 2016 2015 FY

CytomX Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $119,000 +$4,000 +3.5% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $115,000 +$67,000 +140% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $48,000 -$688,000 -93% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $736,000 -$246,000 -25% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $982,000 -$67,000 -6.4% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $1,049,000 -$786,000 -43% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $1,835,000 +$1,084,000 +144% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $751,000 -$193,000 -20% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $944,000 +$617,000 +189% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $327,000 +$72,000 +28% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q1 2015 $255,000 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.